The 10 hottest medtech startups of 2017

Share

NeuSpera

NeuSpera Medical

Technology: Electroceutical neuromodulation therapy

CEO: Milton M. Morris

Website: www.neuspera.com

NeuSpera leverages exclusively licensed mid-field powering techniques to engineer miniaturized injectable neuromodulation technologies (aka electroceuticals). NeuSpera’s implantable module is more than 100 times smaller than other neuromodulation devices and may substantially reduce implant procedure complexity, time, patient complication and post-surgical pain. The idea is that miniature devices can modulate the electrical impulses in the body, triggering biochemical processes more typically manipulated via biopharmaceuticals. The end game is to replace drug therapies by inducing the body to heal itself of major illnesses that could include diabetes, asthma, hypertension, arthritis, pain and even cancer. NeuSpera Medical is committed to bringing forward implantable medical device technology that will improve lives of patients battling with chronic illness. The company raised $8 million in 2016.

Next>>

Don't Miss the Most Anticipated Conference of the Fall!

textadimage DeviceTalks Boston is just a few months away. More than 50 speakers and 35 exhibitors will join over 400 members of this red-hot industry, for a look inside the most important developments facing our community.

Join us for three days of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.

Take a look at our speaker line-up and more.

Pages: 1 2 3 4 5 6 7 8 9 10 11

Comments

  1. Heather, great insights on the changing needs for medtech start-ups. We were thrilled to see, Madorra, one of our collaborating partners make your top 10. Look forward to following your updates on this incredible startup space.

    • Heather Thompson says:

      They are doing some important work. Thanks, Juan. I’m excited to see the latest crop of startups for 2018 as well.

Speak Your Mind

*